Works about DESIGNER drugs

Results: 477
    1
    2
    3
    4
    5
    6

    Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine.

    Published in:
    Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 2, p. 145, doi. 10.1002/hup.1242
    By:
    • Corazza, Ornella;
    • Schifano, Fabrizio;
    • Simonato, Pierluigi;
    • Fergus, Suzanne;
    • Assi, Sulaf;
    • Stair, Jacqueline;
    • Corkery, John;
    • Trincas, Giuseppina;
    • Deluca, Paolo;
    • Davey, Zoe;
    • Blaszko, Ursula;
    • Demetrovics, Zsolt;
    • Moskalewicz, Jacek;
    • Enea, Aurora;
    • Melchiorre, Giuditta;
    • Mervo, Barbara;
    • Furia, Lucia;
    • Farre, Magi;
    • Flesland, Liv;
    • Pasinetti, Manuela
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Genetic deletion of dopamine D1 receptors increases the sensitivity to cannabinoid CB1 receptor antagonist-precipitated withdrawal when compared with wild-type littermates: studies in female mice repeatedly exposed to the Spice cannabinoid HU-210.

    Published in:
    Psychopharmacology, 2021, v. 238, n. 2, p. 551, doi. 10.1007/s00213-020-05704-8
    By:
    • Serrano, Antonia;
    • Vadas, Evelyn;
    • Ferrer, Belen;
    • Bilbao, Ainhoa;
    • Granado, Noelia;
    • Suárez, Juan;
    • Pavon, Francisco Javier;
    • Moratalla, Rosario;
    • Rodríguez de Fonseca, Fernando
    Publication type:
    Article
    19

    The neurobehavioral effects of the designer drug naphyrone – an experimental investigation with pharmacokinetics and concentration/effect relationship in mice.

    Published in:
    Psychopharmacology, 2020, v. 237, n. 7, p. 1943, doi. 10.1007/s00213-020-05510-2
    By:
    • Mégarbane, Bruno;
    • Gamblin, Camille;
    • Roussel, Olivier;
    • Bouaziz-Amar, Elodie;
    • Chevillard, Lucie;
    • Callebert, Jacques;
    • Chen, Huixiong;
    • Morineau, Gilles;
    • Laplanche, Jean-Louis;
    • Etheve-Quelquejeu, Mélanie;
    • Liechti, Matthias E.;
    • Benturquia, Nadia
    Publication type:
    Article
    20
    21
    22
    23
    24
    25

    Holy smoke – high life?

    Published in:
    Nachrichten aus der Chemie, 2022, v. 70, n. 9, p. 76, doi. 10.1002/nadc.20224129508
    Publication type:
    Article
    26

    2C-x and DOx hallucinogens: a systematic review.

    Published in:
    Annals of the University Dunarea de Jos of Galati: Fascicle II, Mathematics, Physics, Theoretical Mechanics, 2021, v. 44, n. 1, p. 46, doi. 10.35219/ann-ugal-math-phys-mec.2021.1.07
    By:
    • Darie, Iulia-Florentina;
    • Praisler, Mirela;
    • Negoita, Catalin
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Pharmacological and Behavioral Effects of the Synthetic Cannabinoid AKB48 in Rats.

    Published in:
    Frontiers in Neuroscience, 2019, v. 13, p. 1, doi. 10.3389/fnins.2019.01163
    By:
    • Bilel, Sabrine;
    • Tirri, Micaela;
    • Arfè, Raffaella;
    • Stopponi, Serena;
    • Soverchia, Laura;
    • Ciccocioppo, Roberto;
    • Frisoni, Paolo;
    • Strano-Rossi, Sabina;
    • Miliano, Cristina;
    • De-Giorgio, Fabio;
    • Serpelloni, Giovanni;
    • Fantinati, Anna;
    • De Luca, Maria Antonietta;
    • Neri, Margherita;
    • Marti, Matteo
    Publication type:
    Article
    44
    45

    Drug Screening in Neonates.

    Published in:
    Neonatal Network, 2016, v. 35, n. 5, p. 321, doi. 10.1891/0730-0832.35.5.321
    By:
    • Givens Bell, Susan
    Publication type:
    Article
    46
    47

    Drugs of Abuse 2012 Update.

    Published in:
    Pediatric Emergency Medicine Reports, 2012, v. 17, n. 12, p. 145
    By:
    • Felter, Robert A.
    Publication type:
    Article
    48
    49
    50

    CNE Quiz.

    Published in:
    Journal of Psychosocial Nursing & Mental Health Services, 2015, v. 53, n. 5, p. 44, doi. 10.3928/02793695-20150428-99
    Publication type:
    Article